Number of the records: 1  

lymfóm veľkobunkový anaplastický

  1. SYSd017728
    LBL
      
    00000cx--j2200000---45--
    005
      
    20240119201317.2
    100
      
    $a 19930615asloy0103----ba0
    152
      
    $b mesh
    250
      
    $a lymfóm veľkobunkový anaplastický $x BL $x CF $x CH $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UL $x UR $x VE $x VI $8 slo
    300
    1-
    $a 2008 (1994) $8 eng
    300
    1-
    $a Lymphoma (1987-1993) $8 eng
    300
    1-
    $a Lymphoma, Large-Cell (1987-1993) $8 eng
    300
    1-
    $a Lymphoma, Non-Hodgkin's (1987-1993) $8 eng
    330
    1-
    $a A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS. $8 eng
    450
      
    $a Anaplastic Large-Cell Lymphoma $5 e $8 eng
    450
      
    $a CD30-Positive Anaplastic Large-Cell Lymphoma $5 e $8 eng
    450
      
    $a Lymphoma, Large-Cell, Ki-1 $5 e $8 eng
    450
      
    $a Ki-1-pozitívny veľkobunkový lymfóm $5 e $8 slo
    450
      
    $a lymfóm veľkobunkový Ki-1 $5 e $8 slo
    450
      
    $a CD30-pozitívny anaplastický veľkobunkový lymfóm $5 e $8 slo
    550
      
    $3 sllk_un_auth*d017730 $Y Ki-1 Antigen $5 F $a Ki-1 antigén
    686
      
    $a C04.557.386.480.750.399
    686
      
    $a C15.604.515.569.480.750.600
    686
      
    $a C20.683.515.761.480.750.399
    750
      
    $a Lymphoma, Large-Cell, Anaplastic $8 eng
    801
    -0
    $a US $b DNLM $c 19930615
    801
    -2
    $a SK $b BA006 $c 20000610
    801
    -2
    $a SK $b BA006 $c 20080721
    801
    -2
    $a SK $b BA006 $c 20181207
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.